Drug-induced liver injury in obesity and nonalcoholic fatty liver disease.
Allard J, Le Guillou D, Begriche K, Fromenty B.
Adv Pharmacol. 2019;85:75-107. doi: 10.1016/bs.apha.2019.01.003. Epub 2019 Feb 20.
A Review on Drug Induced Obesity and Rodent Experimental Models of Obesity in Animals.
Vangoori Y, Suresh BS, Midde ML, Anusha D, Uppala PK.
Maedica (Bucur). 2022 Sep;17(3):706-713. doi: 10.26574/maedica.2022.17.3.706.
Drug-induced liver injury in obesity.
Fromenty B.
J Hepatol. 2013 Apr;58(4):824-6. doi: 10.1016/j.jhep.2012.12.018. Epub 2013 Jan 5.
Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.
Verhaegen AA, Van Gaal LF.
J Endocrinol Invest. 2017 Nov;40(11):1165-1174. doi: 10.1007/s40618-017-0719-6. Epub 2017 Jun 28.
Inflammation and resolution in obesity.
Soták M, Clark M, Suur BE, Börgeson E.
Nat Rev Endocrinol. 2025 Jan;21(1):45-61. doi: 10.1038/s41574-024-01047-y. Epub 2024 Oct 24.
Decreased 5-HT2cR and GHSR1a interaction in antipsychotic drug-induced obesity.
Huang XF, Weston-Green K, Yu Y.
Obes Rev. 2018 Mar;19(3):396-405. doi: 10.1111/obr.12638. Epub 2017 Nov 9.
Glucose-dependent insulinotropic polypeptide (GIP).
Müller TD, Adriaenssens A, Ahrén B, Blüher M, Birkenfeld AL, Campbell JE, Coghlan MP, D'Alessio D, Deacon CF, DelPrato S, Douros JD, Drucker DJ, Figueredo Burgos NS, Flatt PR, Finan B, Gimeno RE, Gribble FM, Hayes MR, Hölscher C, Holst JJ, Knerr PJ, Knop FK, Kusminski CM, Liskiewicz A, Mabilleau G, Mowery SA, Nauck MA, Novikoff A, Reimann F, Roberts AG, Rosenkilde MM, Samms RJ, Scherer PE, Seeley RJ, Sloop KW, Wolfrum C, Wootten D, DiMarchi RD, Tschöp MH.
Mol Metab. 2025 May;95:102118. doi: 10.1016/j.molmet.2025.102118. Epub 2025 Feb 28.
Slow Metabolism-Driven Amplification of Hepatic PPARgamma Agonism Mediates Benzbromarone-Induced Obesity-Specific Liver Injury.
Li G, Hu Y, Zhao H, Peng Z, Shang X, Zhang J, Xie K, Li M, Zhou X, Zhou Q, Li K, Zhou F, Wang H, Xu Z, Liu J, Sun P.
Adv Sci (Weinh). 2025 Jan;12(3):e2409126. doi: 10.1002/advs.202409126. Epub 2024 Nov 29.
Drug-Induced Mitochondrial Toxicity.
Hargreaves IP, Al Shahrani M, Wainwright L, Heales SJ.
Drug Saf. 2016 Jul;39(7):661-74. doi: 10.1007/s40264-016-0417-x.
[Drug induced obesity].
Murakami T, Mizushima Y.
Nihon Rinsho. 1995 Jun;53 Suppl:425-9.
